|
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
RECRUITINGPhase 2Sponsored by Sundance Biosciences, Inc.
Actively Recruiting
PhasePhase 2
SponsorSundance Biosciences, Inc.
Started2026-10
Est. completion2027-06
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT07840326
Summary
The goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.
Eligibility
Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Aged 18-70, inclusive 2. Diagnosis of PPMS or non-active SPMS 3. No MS relapses in the past 2 years 4. Evidence that MS has continued to get worse over time 5. A level of disability that fits the study requirements Exclusion Criteria: 1. Use of certain medications or treatments before the study, or need for these treatments during the study 2. Current participation in another research study 3. Certain abnormal heart rhythm findings on ECG or other heart conditions that may increase risk 4. Certain serious or unstable medical conditions that could make the study unsafe 5. Active infection, recent infection, or a history of repeated infections Additional inclusion and exclusion criteria are outlined in the full study protocol.
Conditions10
Multiple SclerosisNon-Active SPMSNon-Active Secondary Progressive Multiple SclerosisPrimary Progressive MSPrimary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis (PPMS)Secondary Progressive MSSecondary Progressive MS (SPMS)Secondary Progressive Multiple Sclerosis (SPMS)Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
Interventions1
Locations7 sites
Find trials near these locations
Multiple Sclerosis trials in TampaMultiple Sclerosis trials in AtlantaMultiple Sclerosis trials in RaleighMultiple Sclerosis trials in ColumbusMultiple Sclerosis trials in Oklahoma CityMultiple Sclerosis trials in DallasAll trials in FloridaAll trials in GeorgiaAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OklahomaAll trials in Texas
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorSundance Biosciences, Inc.
Started2026-10
Est. completion2027-06
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT07840326